Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
November 2015

Brexpiprazole (Rexulti)
The manufacturer of aripiprazole (Abilify and others), which is now off patent, has released a similar drug called brexpiprazole (Rexulti), which the FDA has approved to treat schizophrenia and as an adjunct to antidepressants for major depressive disorder (MDD).

Medical Marijuana
Several recent reviews question the evidence for the efficacy of medical marijuana and caution about its potential long-term side effects.

In Brief
Vitamin D Deficiency Associated with Increased Cognitive Decline in Older Adults; High-Glycemic Diets Associated with Increased Risk of Depression in Postmenopausal Women

Nitrous Oxide for Depression?
A pilot study of nitrous oxide inhalation for patients with treatment-resistant depression has yielded positive results.

Affiliated Links

The Journal of Clinical Psychiatry

The University of Arizona Health Sciences Center- Department of Psychiatry

American Academy of Child and Adolescent Psychiatry

American Association of Suicidology

American Psychiatric Association

American Society for Adolescent Psychiatry

American Society of Addiction Medicine

American Society of Clinical Psychopharmacology

Autism Society of America

Depression and Bipolar Support Alliance (DBSA)

National Alliance for Research on Schizophrenia and Depression (NARSAD)

National Alliance for the Mentally Ill

National Association of Alcoholism and Drug Abuse Counselors

National Institute of Mental Health

National Mental Health Association